Home
>
National Drug Code (NDC)
>
Tranxene
Tranxene - 67386-301-01 - (clorazepate dipotassium)
Drug Information of Tranxene
| Product NDC: | 67386-301 |
| Proprietary Name: | Tranxene |
| Non Proprietary Name: | clorazepate dipotassium |
| Active Ingredient(s): | 3.75 mg/1 & nbsp; clorazepate dipotassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tranxene
| Product NDC: | 67386-301 |
| Labeler Name: | Lundbeck Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017105 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19720623 |
Package Information of Tranxene
| Package NDC: | 67386-301-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (67386-301-01) |
NDC Information of Tranxene
| NDC Code | 67386-301-01 |
| Proprietary Name | Tranxene |
| Package Description | 100 TABLET in 1 BOTTLE (67386-301-01) |
| Product NDC | 67386-301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clorazepate dipotassium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19720623 |
| Marketing Category Name | NDA |
| Labeler Name | Lundbeck Inc. |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Strength Number | 3.75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |
